• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

弥散加权成像在肝纤维化评估中的应用。

Utility of diffusion-weighted imaging in the evaluation of liver fibrosis.

机构信息

Department of Radiology, Istanbul Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey.

出版信息

Eur Radiol. 2012 Mar;22(3):682-7. doi: 10.1007/s00330-011-2295-z. Epub 2011 Oct 9.

DOI:10.1007/s00330-011-2295-z
PMID:21984447
Abstract

OBJECTIVES

To evaluate the usefulness of diffusion- weighted MRI (DWI) in the detection and staging of liver fibrosis and inflammation.

METHODS

DWI was performed with b-factors of 0, 500 and 1000 s/mm². ADC values were obtained by placing circular regions of interest in four segments of the liver. Differences between the study (n = 34) and control groups' (n = 25) ADC values were examined. Further, this study investigated if and how ADC values were related to fibrosis stages and histological activity index (HAI) scores.

RESULTS

The mean ADC value of the liver was smaller in the study group compared with the control group (P < 0.001). Spearman rho correlation analyses showed lower ADC values were associated with higher fibrosis and HAI scores (P < 0.01). There were statistically significant differences in liver ADC values between each combination of fibrosis stages (e.g. stages 0 and 1, 0 and 2) except for stages 1 and 2.

CONCLUSIONS

ADC values prove to be a valuable technique for the diagnosis of liver fibrosis and inflammation. They can also be useful in fibrosis staging, particularly in distinguishing later stages of fibrosis from intermediate and early stages.

KEY POINTS

Diffusion Weighted MRI is a promising technique for diagnosis of liver fibrosis. Apparent Diffusion Coefficients provide valuable information for staging of liver fibrosis. DWI may offer alternative to biopsy for assessing liver fibrosis.

摘要

目的

评估弥散加权磁共振成像(DWI)在检测和分期肝纤维化和炎症中的作用。

方法

采用 b 值为 0、500 和 1000 s/mm² 的 DWI。通过在肝脏的四个节段放置圆形感兴趣区来获得 ADC 值。检查研究组(n=34)和对照组(n=25)的 ADC 值差异。此外,本研究还探讨了 ADC 值与纤维化分期和组织学活动指数(HAI)评分之间的关系。

结果

研究组肝脏的平均 ADC 值明显低于对照组(P<0.001)。Spearman rho 相关分析表明,较低的 ADC 值与较高的纤维化和 HAI 评分相关(P<0.01)。在每个纤维化分期组合之间(例如,0 期和 1 期、0 期和 2 期),肝脏 ADC 值存在统计学显著差异,但 1 期和 2 期除外。

结论

ADC 值证明是诊断肝纤维化和炎症的一种有价值的技术。它们在纤维化分期中也很有用,特别是在区分纤维化的晚期与中早期阶段。

关键点

弥散加权磁共振成像技术是肝纤维化诊断的有前途的方法。表观弥散系数为肝纤维化分期提供了有价值的信息。DWI 可能为评估肝纤维化提供替代活检的方法。

相似文献

1
Utility of diffusion-weighted imaging in the evaluation of liver fibrosis.弥散加权成像在肝纤维化评估中的应用。
Eur Radiol. 2012 Mar;22(3):682-7. doi: 10.1007/s00330-011-2295-z. Epub 2011 Oct 9.
2
Staging liver fibrosis with DWI: is there an added value for diffusion kurtosis imaging?DWI 对肝纤维化分期:扩散峰度成像是否有附加价值?
Eur Radiol. 2018 Jul;28(7):3041-3049. doi: 10.1007/s00330-017-5245-6. Epub 2018 Jan 30.
3
Utility of diffusion-weighted MRI for assessing liver fibrosis in patients with chronic active hepatitis.弥散加权 MRI 评估慢性活动性肝炎患者肝纤维化的价值。
Diagn Interv Radiol. 2010 Sep;16(3):204-8. doi: 10.4261/1305-3825.DIR.2810-09.1. Epub 2010 Jul 25.
4
Diagnosis of liver fibrosis and cirrhosis with diffusion-weighted imaging: value of normalized apparent diffusion coefficient using the spleen as reference organ.弥散加权成像诊断肝纤维化和肝硬化:应用脾脏作为参照器官的标准化表观弥散系数的价值。
AJR Am J Roentgenol. 2010 Sep;195(3):671-6. doi: 10.2214/AJR.09.3448.
5
Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis.弥散加权 MRI 评估肝纤维化和肝硬化的价值。
AJR Am J Roentgenol. 2009 Dec;193(6):1556-60. doi: 10.2214/AJR.09.2436.
6
[Comparative study on clinical and pathological changes of liver fibrosis with diffusion-weighted imaging].[肝脏纤维化临床与病理变化的磁共振扩散加权成像对比研究]
Zhonghua Yi Xue Za Zhi. 2009 Jul 7;89(25):1757-61.
7
Diffusion-weighted magnetic resonance imaging for the staging of liver fibrosis.弥散加权磁共振成像在肝纤维化分期中的应用。
J Clin Gastroenterol. 2011 Nov-Dec;45(10):885-92. doi: 10.1097/MCG.0b013e318223bd2c.
8
Evaluation of fibrosis and inflammation in diffuse liver diseases using intravoxel incoherent motion diffusion-weighted MR imaging.应用体素内不相干运动弥散加权磁共振成像评价弥漫性肝脏疾病的纤维化和炎症。
Abdom Radiol (NY). 2017 Feb;42(2):468-477. doi: 10.1007/s00261-016-0899-0.
9
Diffusion-weighted magnetic resonance imaging for staging liver fibrosis is less reliable in the presence of fat and iron.弥散加权磁共振成像在存在脂肪和铁的情况下对肝纤维化分期的可靠性较低。
Eur Radiol. 2013 May;23(5):1281-7. doi: 10.1007/s00330-012-2700-2. Epub 2012 Nov 9.
10
The use of DWI to assess spleen and liver quantitative ADC changes in the detection of liver fibrosis stages in chronic viral hepatitis.弥散加权成像(DWI)评估慢性病毒性肝炎肝纤维化分期时肝脏、脾脏 ADC 值定量变化的应用。
Eur J Radiol. 2013 Aug;82(8):e307-12. doi: 10.1016/j.ejrad.2013.02.022. Epub 2013 Mar 19.

引用本文的文献

1
Multi-parameter magnetic resonance imaging of zebularine in liver fibrosis treatment and calcineurin/ mechanism.zebularine在肝纤维化治疗中的多参数磁共振成像及钙调神经磷酸酶/机制
World J Gastroenterol. 2025 May 28;31(20):105554. doi: 10.3748/wjg.v31.i20.105554.
2
Monoexponential and advanced diffusion-weighted imaging for hepatic fibrosis staging based on high inter-examiner reliability.基于高观察者间可靠性的用于肝纤维化分期的单指数和高级弥散加权成像。
Saudi Med J. 2024 Aug;45(9):911-918. doi: 10.15537/smj.2024.45.9.20240057.
3
Technical Advancements in Abdominal Diffusion-weighted Imaging.

本文引用的文献

1
Diffusion-weighted magnetic resonance imaging in evaluation of primary solid and cystic renal masses using the Bosniak classification.弥散加权磁共振成像在 Bosniak 分类法评估原发性实性和囊性肾肿块中的应用。
Eur J Radiol. 2012 May;81(5):815-20. doi: 10.1016/j.ejrad.2011.02.024. Epub 2011 Mar 4.
2
Utility of diffusion-weighted imaging in the diagnosis of acute appendicitis.弥散加权成像在急性阑尾炎诊断中的应用。
Eur Radiol. 2011 Apr;21(4):768-75. doi: 10.1007/s00330-010-1981-6. Epub 2010 Oct 6.
3
Utility of diffusion-weighted MRI for assessing liver fibrosis in patients with chronic active hepatitis.
腹部弥散加权成像技术进展。
Magn Reson Med Sci. 2023 Apr 1;22(2):191-208. doi: 10.2463/mrms.rev.2022-0107. Epub 2023 Mar 15.
4
Quantitative Evaluation of Liver Fibrosis on T1 Relaxometry in Comparison with Fibroscan.与Fibroscan相比,基于T1弛豫测量法对肝纤维化的定量评估
Taehan Yongsang Uihakhoe Chi. 2020 Mar;81(2):365-378. doi: 10.3348/jksr.2020.81.2.365. Epub 2020 Feb 18.
5
Fat- and iron-corrected ADC to assess liver fibrosis in patients with chronic hepatitis B.脂肪和铁校正 ADC 评估慢性乙型肝炎患者的肝纤维化。
Diagn Interv Radiol. 2022 Jan;28(1):5-11. doi: 10.5152/dir.2021.21471.
6
Basics of magnetic resonance imaging and quantitative parameters T1, T2, T2*, T1rho and diffusion-weighted imaging.磁共振成像基础及 T1、T2、T2*、T1rho 和弥散加权成像定量参数。
Pediatr Radiol. 2022 Feb;52(2):217-227. doi: 10.1007/s00247-021-05042-7. Epub 2021 Apr 15.
7
Comparison of MR-PWI quantitative and semi-quantitative parameters for the evaluation of liver fibrosis.MR-PWI 定量和半定量参数在肝纤维化评估中的比较。
BMC Med Imaging. 2021 Jan 6;21(1):8. doi: 10.1186/s12880-020-00539-3.
8
Diffusion-weighted imaging and texture analysis: current role for diffuse liver disease.扩散加权成像和纹理分析:弥漫性肝脏疾病的当前作用。
Abdom Radiol (NY). 2020 Nov;45(11):3523-3531. doi: 10.1007/s00261-020-02772-4. Epub 2020 Oct 16.
9
Diffusion-weighted magnetic resonance imaging and micro-RNA in the diagnosis of hepatic fibrosis in chronic hepatitis C virus.扩散加权磁共振成像及微小RNA在丙型肝炎病毒慢性感染肝纤维化诊断中的应用
World J Gastroenterol. 2019 Mar 21;25(11):1366-1377. doi: 10.3748/wjg.v25.i11.1366.
10
PET/DW-MRI for evaluating treatment in chronic hepatitis C patients.正电子发射断层扫描/扩散加权磁共振成像用于评估慢性丙型肝炎患者的治疗情况。
Am J Nucl Med Mol Imaging. 2019 Feb 15;9(1):84-92. eCollection 2019.
弥散加权 MRI 评估慢性活动性肝炎患者肝纤维化的价值。
Diagn Interv Radiol. 2010 Sep;16(3):204-8. doi: 10.4261/1305-3825.DIR.2810-09.1. Epub 2010 Jul 25.
4
Diffusion weighted imaging in the liver.肝脏弥散加权成像。
World J Gastroenterol. 2010 Apr 7;16(13):1567-76. doi: 10.3748/wjg.v16.i13.1567.
5
Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis.弥散加权 MRI 评估肝纤维化和肝硬化的价值。
AJR Am J Roentgenol. 2009 Dec;193(6):1556-60. doi: 10.2214/AJR.09.2436.
6
Apparent diffusion coefficient in pancreatic cancer: characterization and histopathological correlations.胰腺癌中的表观扩散系数:特征及组织病理学相关性
J Magn Reson Imaging. 2008 Jun;27(6):1302-8. doi: 10.1002/jmri.21340.
7
Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology.背景体部信号抑制的扩散加权全身成像(DWIBS):肿瘤学中的特征及潜在应用
Eur Radiol. 2008 Sep;18(9):1937-52. doi: 10.1007/s00330-008-0968-z. Epub 2008 Apr 30.
8
Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging--initial experience.晚期肝纤维化:三维全肝灌注磁共振成像诊断——初步经验
Radiology. 2008 Mar;246(3):926-34. doi: 10.1148/radiol.2463070077. Epub 2008 Jan 14.
9
Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience.扩散加权磁共振成像用于肝纤维化定量评估:初步经验
AJR Am J Roentgenol. 2007 Oct;189(4):799-806. doi: 10.2214/AJR.07.2086.
10
Amelioration of hepatic fibrosis via beta-glucosylceramide-mediated immune modulation is associated with altered CD8 and NKT lymphocyte distribution.通过β-葡萄糖神经酰胺介导的免疫调节改善肝纤维化与CD8和NKT淋巴细胞分布改变有关。
Int Immunol. 2007 Aug;19(8):1021-9. doi: 10.1093/intimm/dxm069. Epub 2007 Aug 13.